Home - Products - Others - Other Targets - 26-Dihydroxypyridine hydrochloride

26-Dihydroxypyridine hydrochloride

CAS No. 10357-84-3

26-Dihydroxypyridine hydrochloride( —— )

Catalog No. M19540 CAS No. 10357-84-3

26-Dihydroxypyridine hydrochloride is used as a reagent to synthesize uridine phosphorylase inhibitors that increase Uridine (Urd) (U829910) levels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
100MG Get Quote In Stock
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    26-Dihydroxypyridine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    26-Dihydroxypyridine hydrochloride is used as a reagent to synthesize uridine phosphorylase inhibitors that increase Uridine (Urd) (U829910) levels.
  • Description
    26-Dihydroxypyridine hydrochloride is used as a reagent to synthesize uridine phosphorylase inhibitors that increase Uridine (Urd) (U829910) levels. Uridine is a promising biochemical modulator to reduce 5-fluorouracil (5-FU) toxicity without impairing its antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10357-84-3
  • Formula Weight
    147.56
  • Molecular Formula
    C5H6ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    Cl.Oc1cccc(O)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Renck D et al. Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis inhibition studies thermodynamics and in vitro influence on 5-fluorouracil cytotoxicity. J Med Chem. 2013 Nov 14;56(21):8892-902.
molnova catalog
related products
  • SPR741

    SPR741, formerly NAB741 (12), is a cationic peptide derived from polymyxin B and is one such potentiator molecule that is under development for the treatment of serious Gram-negative bacterial infections.

  • UK-396082

    UK-396082 is a potent and selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (activated TAFI; TAFIa) with Ki of 10 nM.

  • (3β,4α,7β,15α)-3,7,1...

    3β,7β,15α-Trihydroxy-4-(hydroxymethyl)-11,23-dioxo-lanost-8-en-26-oic acid is a triterpene compound that can be found in Ganoderma lucidum, and it inhibits nitric oxide (NO) production in BV-2 microglial cells induced by lipopolysaccharide (LPS), with an IC50 of 4.15 μM.